Number of the records: 1
Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides for therapeutic use
- 1.0532882 - ÚOCHB 2021 RIV eng P - Patent Document
Hocek, Michal - Tokarenko, Anna - Smolen, Sabina - Hajdúch, M. - Džubák, P.
Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides for therapeutic use.
2020. Owner: Ústav organické chemie a biochemie AV ČR, v. v. i. - Univerzita Palackého v Olomouci. Date of the patent acceptance: 04.08.2020. Patent Number: US10730905
R&D Projects: GA ČR(CZ) GA16-00178S; GA TA ČR(CZ) TE01020028; GA MŠMT(CZ) EF16_019/0000729
Institutional support: RVO:61388963
Keywords : nucleosides * cytostatics * deazapurines
OECD category: Medicinal chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20200804&DB=&locale=en_EP&CC=US&NR=10730905B2&KC=B2&ND=4
Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides of general formula I, where R is selected from the group comprising furan-2-yl, furan-3-yl, benzofuran-2-yl, methylsulfanyl, methoxy, amino, dimethylamino, methyl or chloro, and pharmaceutically acceptable salt thereof, their optical isomers and mixtures of such optical isomers.
Permanent Link: http://hdl.handle.net/11104/0311283
Number of the records: 1